Health ❯Healthcare
Cancer Research Cancer Treatment Medical Research Patient Care Clinical Trials Cancer Oncology Molecular Biology Public Health Clinical Research
Phase III data validate December’s accelerated FDA decision by confirming the encorafenib, cetuximab and mFOLFOX6 combination as a new standard of care for this aggressive molecularly defined disease.